Leading A Government-Wide Response To Long COVID — Dr. Ian Simon, Ph.D. — Director, Office of Long COVID Research and Practice, Office of the Assistant Secretary for Health (OASH), U.S. Department of Health and Human Services (HHS)
Dr. Ian Simon, Ph.D. is the Director for the Office of Long COVID Research and Practice (https://www.hhs.gov/longcovid/index.html), in the Office of Science and Medicine, in the Office of the Assistant Secretary for Health at the U.S. Department of Health \& Human Services.
The Office of Science and Medicine harnesses the power of collaboration, scientific analysis, data-driven innovation, and emerging technologies for advancing initiatives across the Department, including not just Long COVID, but in the areas of behavioral health, health equity, kidney disease, infection-associated chronic conditions, mother-infant dyad, sickle cell disease, and traumatic brain injury.
We’ve detected that JavaScript is disabled in this browser. Please enable JavaScript or switch to a supported browser to continue using x.com. You can see a list of supported browsers in our Help Center.
SpaceX is preparing to launch the seventh Starship flight test. The window for the launch opens at 4 p.m. local time on Monday. The company has confirmed on its website, and X, that it is targeting a potential catch of the Super Heavy booster, if flight parameters allow for it. SpaceX will also try to re-ignite a single Raptor engine in space to demonstrate deorbit capabilities. This flight is the first one, that will feature the new upgraded Starship upper stage!
Window Opens: January 15th at 4PM CST (22:00 UTC) Window Closes: January 15th at 5PM CST (23:00 UTC)
Mission: Starship’s seventh fully integrated test flight. Launch location: Orbital Launch Pad A, Starbase, Earth. Target orbit: Trans-atmospheric. Booster: Booster 14 Booster recovery: Orbital Launch Pad A launch tower arms. Ship: Ship 33 Ship recovery: Will attempt soft splashdown on the Indian Ocean. Rocket trajectory: Straight east over the Gulf of Mexico. Payload: 10 Starlink simulators. Stats: · SpaceX’s 7th launch of the year and the 7th launch of the month. · Starship’s 7th launch. · 3rd Super Heavy recovery attempt, hopefully the 2nd successful one.
⚡ Become a member of NASASpaceflight’s channel for exclusive discord access, fast turnaround clips, and other exclusive benefits. Your support helps us continue our 24/7 coverage. ⚡
Exploring the most important questions we face as we age.
Dr. Debra Whitman, Ph.D. is Executive Vice President and Chief Public Policy Officer, at AARP (https://www.aarp.org/) where she leads policy development, analysis and research, as well as global thought leadership supporting and advancing the interests of individuals age 50-plus and their families. She oversees AARP’s Public Policy Institute, AARP Research, Office of Policy Development and Integration, Thought Leadership, and AARP International.
Dr. Whitman is an authority on aging issues with extensive experience in national policy making, domestic and international research, and the political process. An economist, she is a strategic thinker whose career has been dedicated to solving problems affecting economic and health security, and other issues related to population aging.
Improving Global Resilience Against Emerging Infectious Threats — Dr. Nahid Bhadelia, MD — Founding Director, Center on Emerging Infectious Diseases (CEID), Boston University.
Dr. Nahid Bhadelia, MD, MALD is a board-certified infectious diseases physician who is the Founding Director of BU Center on Emerging Infectious Diseases (https://www.bu.edu/ceid/about-the-cen…) as well an Associate Professor at the BU School of Medicine. She served the Senior Policy Advisor for Global COVID-19 Response for the White House COVID-19 Response Team in 2022–2023, where she coordinated the interagency programs for global COVID-19 vaccine donations from the United States and was the policy lead for Project NextGen, $5B HHS program aimed at developing next generation vaccines and treatments for pandemic prone coronaviruses. She also served as the interim Testing Coordinator for the White House MPOX Response Team. She is the Director and co-founder of Biothreats Emergence, Analysis and Communications Network (BEACON), an open source outbreak surveillance program.
Between 2011–2021, Dr. Bhadelia helped develop and then served as the medical director of the Special Pathogens Unit (SPU) at Boston Medical Center, a medical unit designed to care for patients with highly communicable diseases, and a state designated Ebola Treatment Center. She was previously an associate director for BU’s maximum containment research program, the National Emerging Infectious Diseases Laboratories. She has provided direct patient care and been part of outbreak response and medical countermeasures research during multiple Ebola virus disease outbreaks in West and East Africa between 2014–2019. She was the clinical lead for a DoD-funded viral hemorrhagic fever clinical research unit in Uganda, entitled Joint Mobile Emerging Disease Intervention Clinical Capability (JMEDICC) program between 2017 and 2022. Currently, she is a co-director of Fogarty funded, BU-University of Liberia Emerging and Epidemic Viruses Research training program. She was a member of the World Health Organization(WHO)’s Technical Advisory Group on Universal Health and Preparedness Review (UHPR). She currently serves as a member of the National Academies Forum on Microbial Threats and previously served as the chair of the National Academies Workshop Committee for Potential Research Priorities to Inform Readiness and Response to Highly Pathogenic Avian Influenza A (H5N1) and member of the Ad Hoc Committee on Current State of Research, Development, and Stockpiling of Smallpox Medical Countermeasures.
Cybersecurity researchers have found that bad actors are continuing to have success by spoofing sender email addresses as part of various malspam campaigns.
Faking the sender address of an email is widely seen as an attempt to make the digital missive more legitimate and get past security mechanisms that could otherwise flag it as malicious.
While there are safeguards such as DomainKeys Identified Mail (DKIM), Domain-based Message Authentication, Reporting and Conformance (DMARC), and Sender Policy Framework (SPF) that can be used to prevent spammers from spoofing well-known domains, such measures have increasingly led them to leverage old, neglected domains in their operations.
Have you ever wondered what hidden truths are being kept from you about the coming AI revolution? The rapid advancement of artificial intelligence is creating waves of change, but are there crucial aspects that the mainstream isn’t revealing? In this eye-opening video, we dive deep into the 10 things they’re not telling you about the future of AI. From secretive developments to potential societal impacts, this video will reveal the truth behind the hype and what you need to know to stay ahead.
We’ll explore the unspoken implications of AI advancements and how they might affect various industries and everyday life. Discover the hidden agendas and overlooked details that could shape the future of technology and its integration into our daily routines. Whether you’re an AI enthusiast, a tech professional, or simply curious about the future, this video provides essential insights you won’t want to miss.
The coming AI era is not just about technological advancements but also about the underlying narratives that influence public perception and policy decisions. Stay informed and prepared by understanding the full picture of what AI could mean for you and the world at large.
What are the hidden truths about the future of AI?How will the coming AI revolution affect us?What are the secrets behind artificial intelligence advancements?What are the unspoken implications of AI technology?This video will address all these questions. Make sure to watch until the end to get the complete story.
Genesis supports parallel simulation, making it ideal for training reinforcement learning (RL) locomotion policies efficiently. In this tutorial, we will walk you through a complete training example for obtaining a basic locomotion policy that enables a Unitree Go2 Robot to walk. With Genesis, you will be able to train a locomotion policy that’s deployable in real-world in less than 26 seconds (benchmarked on a RTX 4090).
Acknowledgement: This tutorial is inspired by and builds several core concepts from Legged Gym.
Delivering Innovative, Compassionate And Accessible Patient Care — Robert Stone, CEO — City of Hope & Dr. Marcel van den Brink, MD, PhD, President, City of Hope Comprehensive Cancer Center.
Robert Stone is the CEO of City of Hope (https://www.cityofhope.org/robert-stone), a premier cancer research and treatment center dedicated to innovation in biomedical science and the delivery of compassionate, world-class patient care. A seasoned health care executive, he has served in a number of strategic decision-making roles since he joined City of Hope in 1996, culminating with his appointment as president in 2012, CEO in 2014, and as the Helen and Morgan Chu Chief Executive Officer Distinguished Chair in 2021.
Mr. Stone has J.D., University of Chicago Law School, Chicago, IL.
Mike has over 15 years of experience in healthcare, including extensive experience designing and developing medical devices. MedCrypt, Inc.
On October 1, 2024, the Food and Drug Administration (FDA) marked a major milestone in medical device cybersecurity enforcement. This marks one year since the retracted Refuse to Accept (RTA) policy and the full implementation of the Protecting and Transforming Cyber Healthcare (PATCH) Act amendment to the Food, Drug & Cosmetic Act (FD&C). The FDA’s new requirements represent a fundamental shift in the regulatory landscape for medical device manufacturers (MDMs), as cybersecurity is now a non-negotiable element of device development and compliance.
The timing is not coincidental. In 2023, the FDA issued its final guidance entitled “Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions.” This outlined the detailed cybersecurity requirements and considerations that MDMs must address in their submissions, highlighting the security measures in place to gain regulatory approval. With these requirements, the FDA is taking a hard stance: Cybersecurity is a core consideration, with compliance being systematically enforced.
